Skip to content

The Evaluation of White Matter Intensities in Patients with Pediatric Epilepsy

The Evaluation of White Matter Intensities in Patients with Pediatric Epilepsy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06887504
Enrollment
173
Registered
2025-03-20
Start date
2019-08-01
Completion date
2024-04-01
Last updated
2025-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsies, White Matter Alterations

Keywords

Children, epilepsy, white matter, hyperintensity

Brief summary

Aim: Neuroimaging is an important tool, in combination with a detailed medical history, physical examination, and electroencephalography, in the diagnosis and classification of epilepsy. White matter hyperintensities (WMHs) are bright areas of high signal intensity seen in white matter at T2-weighted MRI. Researchers aimed to evaluate whether white matter hyperintensities are more common in children with epilepsy. Material-method: Patients who underwent cranial MRI with diagnoses of epilepsy based on International League Against Epilepsy (ILAE) criteria at the Balıkesir University Medical Faculty Pediatric neurology clinic, Türkiye, between 01.08.2019 and 01.03.2024 and patients who underwent cranial MRI during the same period due to indications other than epilepsy, such as headache, syncope, and vertigo, were included in the study. Written informed consent was received from all patients.

Detailed description

Aim: Neuroimaging is an important tool, in combination with a detailed medical history, physical examination, and electroencephalography, in the diagnosis and classification of epilepsy. White matter hyperintensities (WMHs) are bright areas of high signal intensity seen in white matter at T2-weighted MRI. Researchers aimed to evaluate whether white matter hyperintensities are more common in children with epilepsy. Material-method: Patients who underwent cranial MRI with diagnoses of epilepsy based on International League Against Epilepsy (ILAE) criteria at the Balıkesir University Medical Faculty Pediatric neurology clinic, Türkiye, between 01.08.2019 and 01.03.2024 and patients who underwent cranial MRI during the same period due to indications other than epilepsy, such as headache, syncope, and vertigo, were included in the study. Written informed consent was received from all patients.

Interventions

None listed

Sponsors

Aysen Orman
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
5 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

Cranial MRI during the same period due to indications other than epilepsy; * headache * syncope and * vertigo

Exclusion criteria

Patients with neuropsychiatric disorders; * depression, * psychotic disorders, * autism spectrum disorder History of medication use for any chronic disease other than seizure medication, History of vascular disease ; * Collagen tissue diseases; * lupus, * juvenile rheumatoid arthritis, * polyarteritis nodosa, * Kawasaki disease Demyelinating disease * acute demyelinating disease (ADEM), * Multiple sclerosis Acute symptomatic seizure or a single unprovoked seizure, İncomplete file data, or MRI performed at a location other than our hospital

Design outcomes

Primary

MeasureTime frameDescription
The Evaluation of White Matter Intensities in Patients with Pediatric Epilepsy01.08.2019 and 01.03.2024To determine whether white matter hyperintensities are more frequent in children with epilepsy by comparing epilepsy and control groups.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026